CHICAGO ― The data are preliminary, but the results are striking, demonstrating that an immunotherapy approach using adoptive T-cell therapy may have a role in the treatment of advanced cervical ...
The FDA and Corbus Pharmaceuticals Holdings, Inc., have agreed on second-line registrational study designs evaluating CRB-701 ...
Cervical squamous cell carcinoma is one of the predominant histological subtypes of cervical cancer, with significant morbidity and mortality globally. Its management increasingly relies on the ...
A new research paper was published in Volume 16 of Genes & Cancer on August 6, 2025, titled "Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in HeLa cells." In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results